(183) validated the radiosensitizing effect of DNA-dependent protein kinase inhibitors by combining them with PARP1 inhibitors in non-small cell lung cancer cells and found that the main mechanism was accelerated cellular senescence. The gene discussed is PARP1; the disease is non-small cell lung carcinoma.